Evidence map›Paper›PMID 35625712›Full record

ArticleBiomedicines2022

Incorporation of Oxidized Phenylalanine Derivatives into Insulin Signaling Relevant Proteins May Link Oxidative Stress to Signaling Conditions Underlying Chronic Insulin Resistance.

Judit Mohás-Cseh, Gergő Attila Molnár, Marianna Pap, Boglárka Laczy, Tibor Vas, Melinda Kertész, Krisztina Németh, Csaba Hetényi, Orsolya Csikós, Gábor K Tóth and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Judit Mohás-Cseh2nd Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, 7624 Pécs, Hungary.
Gergő Attila Molnár2nd Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, 7624 Pécs, Hungary.ORCID 0000-0001-6052-5907
Marianna PapDepartment of Medical Biology and Central Electron Microscopic Laboratory, University of Pécs Medical School, 7643 Pécs, Hungary.
Boglárka Laczy2nd Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, 7624 Pécs, Hungary.
Tibor Vas2nd Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, 7624 Pécs, Hungary.
Melinda Kertész2nd Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, 7624 Pécs, Hungary.
Krisztina NémethInstitute of Organic Chemistry, Research Centre for Natural Sciences, 1117 Budapest, Hungary.ORCID 0000-0003-1360-7648
Csaba HetényiDepartment of Pharmacology and Pharmacotherapy, University of Pécs Medical School, 7643 Pécs, Hungary.ORCID 0000-0002-8013-971X
Orsolya CsikósDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
Gábor K TóthDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
Attila ReményiInstitute of Organic Chemistry, Research Centre for Natural Sciences, 1117 Budapest, Hungary.ORCID 0000-0002-8345-1311
István Wittmann2nd Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, 7624 Pécs, Hungary.ORCID 0000-0001-5163-5733
University of Pecs · HUInstitute of Organic Chemistry · HUUniversity of Szeged · HU

Funding

National Research, Development and Innovation Office KKP 126963National Research, Development and Innovation Office TKP2021-EGA-32National Research, Development and Innovation Office VEKOP-2.3.3-15-2016-00011
6 · The paper itself

Abstract

A link between oxidative stress and insulin resistance has been suggested. Hydroxyl free radicals are known to be able to convert phenylalanine (Phe) into the non-physiological tyrosine isoforms ortho- and meta-tyrosine (o-Tyr, m-Tyr). The aim of our study was to examine the role of o-Tyr and m-Tyr in the development of insulin resistance. We found that insulin-induced uptake of glucose was blunted in cultures of 3T3-L1 grown on media containing o- or m-Tyr. We show that these modified amino acids are incorporated into cellular proteins. We focused on insulin receptor substrate 1 (IRS-1), which plays a role in insulin signaling. The activating phosphorylation of IRS-1 was increased by insulin, the effect of which was abolished in cells grown in m-Tyr or o-Tyr media. We found that phosphorylation of m- or o-Tyr containing IRS-1 segments by insulin receptor (IR) kinase was greatly reduced, PTP-1B phosphatase was incapable of dephosphorylating phosphorylated m- or o-Tyr IRS-1 peptides, and the SH2 domains of phosphoinositide 3-kinase (PI3K) bound the o-Tyr IRS-1 peptides with greatly reduced affinity. According to our data, m- or o-Tyr incorporation into IRS-1 modifies its protein-protein interactions with regulating enzymes and effectors, thus IRS-1 eventually loses its capacity to play its role in insulin signaling, leading to insulin resistance.

Indexed as

dephosphorylationhydroxyl free radicalinsulin resistanceIRS-1meta-tyrosineortho-tyrosineoxidative stressphosphorylation

Identifiers

PMID35625712
PMCPMC9138545
OpenAlexW4224317404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.